Browsing by Subject "Disease progression"
Now showing items 1-2 of 2
-
(Sociedad Medica de Santiago, 2014)Background: Immunomodulatory drugs (IMD), Interferon β1a, β1 b and glatiramer acetate are available in the Chilean public health system since June 2008 for patients with relapsing-remitting multiple sclerosis (RR-MS). ...
-
(Sociedad Médica de Santiago, 2014)Background: Immunomodulatory drugs (IMD), Interferon β1a, β1 b and glatiramer acetate are available in the Chilean public health system since June 2008 for patients with relapsing-remitting multiple sclerosis (RR-MS). ...